Read + Share
Amedeo Smart
Independent Medical Education
Heo S, Park Y, Lee N, Kim Y, et al. Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation. Transplant Proc 2022 Sep 30. pii: S0041-1345(22)00503.PMID: 36192209
Email
LinkedIn
Facebook
Twitter
Privacy Policy